Glycemic Control and Infections Among US Hemodialysis Patients With Diabetes Mellitus - PubMed

Last updated: 10-31-2020

Read original article here

Glycemic Control and Infections Among US Hemodialysis Patients With Diabetes Mellitus - PubMed

doi: 10.1016/j.ekir.2020.04.020. eCollection 2020 Jul.
Glycemic Control and Infections Among US Hemodialysis Patients With Diabetes Mellitus
1 Department of Medicine, Division of Nephrology, Stanford University School of Medicine, Stanford, California, USA.
2 Stanford Diabetes Research Center, Stanford University School of Medicine, Stanford, California, USA.
3 Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, USA.
4 Section of Infectious Diseases, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
5 Department of Medicine, University of California at San Francisco, San Francisco, California, USA.
6 Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
PMID: 32647759
Glycemic Control and Infections Among US Hemodialysis Patients With Diabetes Mellitus
Jinnie J Rhee et al. Kidney Int Rep.
2020
doi: 10.1016/j.ekir.2020.04.020. eCollection 2020 Jul.
Authors
1 Department of Medicine, Division of Nephrology, Stanford University School of Medicine, Stanford, California, USA.
2 Stanford Diabetes Research Center, Stanford University School of Medicine, Stanford, California, USA.
3 Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, USA.
4 Section of Infectious Diseases, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
5 Department of Medicine, University of California at San Francisco, San Francisco, California, USA.
6 Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
PMID: 32647759
Abstract
Introduction: Patients with diabetes mellitus (DM) on hemodialysis (HD) may be particularly vulnerable to infections.
Methods: We used merged data from the United States Renal Data System and electronic health records data from a large US dialysis provider to retrospectively examine the association between glycemic control and infections in these patients. Adult patients with DM aged ≥18 years who initiated in-center maintenance HD treatment from 2006 to 2011 and survived >90 days were included. Quarterly mean time-averaged hemoglobin A1c (HbA1c) values were categorized into


Read the rest of this article here